company-logo

Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases. The company's therapeutics programs include the development of a chimeric endocrine receptor T-cell technology, a novel form of chimeric antigen receptor T-cell (CAR-T) technology focusing on the treatment of ovarian cancer; and the discovery and development of anti-viral drug candidates for the treatment of COVID-19 focused on inhibiting certain protein functions of the virus. Its vaccine programs comprise the development of a vaccine against triple negative breast cancer; and a preventative vaccine against ovarian cancer. The company is also developing immuno-therapy drugs against cancer. It has a collaboration agreement with MolGenie GmbH to discover and develop anti-viral drug candidates against COVID-19. The company was formerly known as ITUS Corporation and changed its name to Anixa Biosciences, Inc. in October 2018. Anixa Biosciences, Inc. was incorporated in 1982 and is based in San Jose, California.

Anixa Biosciences Dividend Announcement

Anixa Biosciences does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
Stay tuned for updates on Anixa Biosciences dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Anixa Biosciences Dividend History

Anixa Biosciences Dividend Yield

Anixa Biosciences current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Anixa Biosciences stock? Use our calculator to estimate your expected dividend yield:

Anixa Biosciences Financial Ratios

P/E ratio-8.35
PEG ratio1.03
P/B ratio4.74
ROE-52.41%
Payout ratio0.00%
Current ratio11.31
Quick ratio11.31
Cash Ratio0.61

Anixa Biosciences Dividend FAQ

Does Anixa Biosciences stock pay dividends?
Anixa Biosciences does not currently pay dividends to its shareholders.
Has Anixa Biosciences ever paid a dividend?
No, Anixa Biosciences has no a history of paying dividends to its shareholders. Anixa Biosciences is not known for its dividend payments.
Why doesn't Anixa Biosciences pay dividends?
There are several potential reasons why Anixa Biosciences would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Anixa Biosciences ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Anixa Biosciences has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Anixa Biosciences a dividend aristocrat?
Anixa Biosciences is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Anixa Biosciences a dividend king?
Anixa Biosciences is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Anixa Biosciences a dividend stock?
No, Anixa Biosciences is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Anixa Biosciences stocks?
To buy Anixa Biosciences you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Anixa Biosciences stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.